← FDA DRUG APPROVALS

FDA NDA · NDA050314

FUNGIZONE

Sponsor: APOTHECON

APPLICATION
NDA050314
TYPE
NDA
ORIGINAL APPROVAL
1966-02-07
LATEST ACTION
1996-06-13
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

FUNGIZONEDiscontinued
AMPHOTERICIN B 3% · CREAM · TOPICAL

Approval history

1996-06-13Manufacturing (CMC) · Supplement 29AP
1993-05-07Manufacturing (CMC) · Supplement 6AP
1978-08-24Manufacturing (CMC) · Supplement 17AP
1978-06-12Manufacturing (CMC) · Supplement 15AP
1975-11-28Manufacturing (CMC) · Supplement 14AP
1971-01-12Labeling · Supplement 7AP
1966-02-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →